Anatomically selective serotonergic type 1A and serotonergic type 2A therapies for Parkinson's disease: an approach to reducing dyskinesia without exacerbating parkinsonism? [electronic resource]
Producer: 20111122Description: 2-8 p. digitalISSN:- 1521-0103
- Animals
- Antiparkinson Agents -- pharmacology
- Dyskinesia, Drug-Induced -- drug therapy
- Humans
- MPTP Poisoning -- drug therapy
- Parkinson Disease -- drug therapy
- Receptor, Serotonin, 5-HT1A -- drug effects
- Receptor, Serotonin, 5-HT2A -- drug effects
- Serotonin Agents -- pharmacology
- Synaptic Transmission -- drug effects
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
There are no comments on this title.
Log in to your account to post a comment.